000 01487 a2200409 4500
005 20250515110036.0
264 0 _c20080923
008 200809s 0 0 eng d
022 _a0271-9142
024 7 _a10.1007/s10875-008-9180-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFasth, Anders
245 0 0 _aQuality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin.
_h[electronic resource]
260 _bJournal of clinical immunology
_cJul 2008
300 _a370-8 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aCaregivers
_xpsychology
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aFamily
_xpsychology
650 0 4 _aFemale
650 0 4 _aHospitalization
650 0 4 _aHumans
650 0 4 _aImmunoglobulins
_xadministration & dosage
650 0 4 _aImmunologic Deficiency Syndromes
_xdrug therapy
650 0 4 _aInfant
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMale
650 0 4 _aOffice Visits
650 0 4 _aPatient Satisfaction
650 0 4 _aQuality of Life
650 0 4 _aSurveys and Questionnaires
700 1 _aNyström, Jeanette
773 0 _tJournal of clinical immunology
_gvol. 28
_gno. 4
_gp. 370-8
856 4 0 _uhttps://doi.org/10.1007/s10875-008-9180-9
_zAvailable from publisher's website
999 _c17762502
_d17762502